Health CanadaGeneral Alert
IMOVANE (zopiclone) - New Dosage Recommendations to Minimize the Risk of Next-Da...
Published: November 19, 2014Recall ID: 52884Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
IMOVANE (zopiclone) - New Dosage Recommendations to Minimize the Risk of Next-Day Impairment - For the Public
Additional Source Details
| Field | Value |
|---|---|
| N I D | 52884 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/imovane-zopiclone-new-dosage-recommendations-minimize-risk-next-day-impairment-public |
| Issue | Product safety |
| Title | IMOVANE (zopiclone) - New Dosage Recommendations to Minimize the Risk of Next-Day Impairment - For the Public |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2014-11-19 |
| Organization | Marketed health products |